SAN DIEGO (AP) — SAN DIEGO (AP) — Neurocrine Biosciences Inc. (NBIX) on Monday reported third-quarter earnings of $206.5 million.

The San Diego-based company said it had net income of $1.96 per share. Earnings, adjusted for one-time gains and costs, were $3.29 per share.

The results exceeded Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of $2.54 per share.

The biopharmaceutical company posted revenue of $1.12 billion in the period, also topping Street forecasts. Nine analysts surveyed by Zacks expected $1.04 billion.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NBIX at https://www.zacks.com/ap/NBIX